Medtronic's restructuring lifts company share price
This article was originally published in Clinica
Following the acquisition of Arterial Vascular Engineering, Medtronic is restructuring its operations. It will close half its 10 vascular products factories with the consequent loss of some 1,600 jobs. The news last week boosted the company's share price by more than 5%.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.